Related Experiment Video
Updated: Jun 20, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Cytochrome P450 enzymes and the heart
Ketul R Chaudhary1, Sri Nagarjun Batchu, John M Seubert
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2N8, Canada.
Cytochrome P450 (CYP) enzymes in the heart are crucial for drug metabolism and cardiovascular health. Understanding genetic variations and environmental impacts on CYP activity is vital for treating heart disease.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiology
Background:
- Cytochrome P450 (CYP) enzymes are critical for metabolizing endogenous and foreign compounds.
- Altered CYP activity, due to genetic, environmental, or pathological factors, significantly impacts drug response.
- The role of CYP enzymes in cardiac physiology and pathophysiology remains largely unexplored.
Purpose of the Study:
- To investigate the expression and functional roles of CYP isoforms in the heart.
- To examine the impact of genetic variations on cardiac CYP activity.
- To highlight the significance of CYP in cardiovascular disease pathogenesis and risk assessment.
Main Methods:
- Review of existing literature on CYP expression and function in cardiac tissue.
- Analysis of studies linking traditional cardiovascular risk factors to CYP activity.
- Exploration of environmental chemical exposure effects on the cardiovascular system and CYP enzymes.
Main Results:
- Cardiac tissue expresses active CYP enzymes, influencing cellular homeostasis and injury.
- CYP activity is affected by genetic variations, drug interactions, and environmental factors.
- Altered CYP function has implications for both detoxification and bioactivation pathways in the heart.
Conclusions:
- Further research into cardiac CYP is warranted to understand its role in heart disease.
- Understanding CYP variations can improve cardiovascular risk assessment and therapeutic strategies.
- CYP enzymes represent a potential target for managing cardiovascular conditions.
More Related Videos
14:56Investigating Cardiac Metabolism in the Isolated Perfused Mouse Heart with Hyperpolarized [1-13C]Pyruvate and 13C/31P NMR Spectroscopy
Published on: April 21, 2023
08:51Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
Published on: May 12, 2019
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacokinetics: Drug–Drug Interactions
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Electron Transport Chain: Complex III and IV
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow